Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Oxford Eye Hospital, John Radcliffe Hospital, Oxford University NHS Foundation Trust, Oxford, UK.
Acta Ophthalmol. 2018 Apr;96 Suppl A111:1-51. doi: 10.1111/aos.13678.
Diabetic retinopathy, a complication of both type 1 and type 2 diabetes, is a complex disease and is one of the leading causes of blindness in adults worldwide. It can be divided into distinct subclasses, one of which is diabetic macular oedema. Diabetic macular oedema can occur at any time in diabetic retinopathy and is the most common cause of vision loss in patients with type 2 diabetes. The purpose of this review is to summarize the large number of genetic association studies that have been performed in cohorts of patients with type 2 diabetes and published in English-language journals up to February 2017. Many of these studies have produced positive associations with gene polymorphisms and diabetic retinopathy. However, this review highlights that within this large body of work, studies specifically addressing a genetic association with diabetic macular oedema, although present, are vastly under-represented. We also highlight that many of the studies have small patient numbers and that meta-analyses often inappropriately combine patient data sets. We conclude that there will continue to be conflicting results and no meaningful findings will be achieved if the historical approach of combining all diabetic retinopathy disease states within patient cohorts continues in future studies. This review also identifies several genes that would be interesting to analyse in large, well-defined cohorts of patients with diabetic macular oedema in future candidate gene association studies.
糖尿病视网膜病变是 1 型和 2 型糖尿病的并发症,是一种复杂的疾病,也是全球成年人致盲的主要原因之一。它可以分为不同的亚型,其中之一是糖尿病黄斑水肿。糖尿病黄斑水肿可在糖尿病视网膜病变的任何时间发生,是 2 型糖尿病患者视力丧失的最常见原因。本综述的目的是总结截至 2017 年 2 月,在以 2 型糖尿病患者为对象的队列中进行并以英文期刊发表的大量遗传关联研究。这些研究中有许多与基因多态性和糖尿病视网膜病变呈正相关。然而,本综述强调,在大量的研究中,尽管有专门针对糖尿病黄斑水肿遗传相关性的研究,但数量非常少。我们还强调,许多研究的患者数量较少,荟萃分析往往不恰当地合并患者数据集。我们的结论是,如果在未来的研究中继续沿用将所有糖尿病视网膜病变疾病状态合并在患者队列中的历史方法,将会有持续的矛盾结果,并且不会有有意义的发现。本综述还确定了一些基因,如果在未来的候选基因关联研究中,在有大量、明确界定的糖尿病黄斑水肿患者队列中进行分析,将是非常有趣的。